How Cancer Research Horizons is building the future of childhood cancer medicines

Cancer is still the leading cause of death by disease in children and young people — yet in the last twenty years, only a handful of drugs have been approved specifically to treat it. Most paediatric cancer treatments are simply adult drugs, repurposed, often at real long-term cost to the children who survive. Today's guest is working to change that, and much more besides. Tony Hickson is Chief Business Officer for Cancer Research Horizons, Cancer Research UK's innovation engine, respon...